16-67657613-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BP4_Strong
The NM_001082486.2(ACD):c.1370C>T(p.Pro457Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000489 in 1,614,130 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_001082486.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ACD | NM_001082486.2 | c.1370C>T | p.Pro457Leu | missense_variant | 12/12 | ENST00000620761.6 | NP_001075955.2 | |
CARMIL2 | NM_001013838.3 | downstream_gene_variant | ENST00000334583.11 | NP_001013860.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ACD | ENST00000620761.6 | c.1370C>T | p.Pro457Leu | missense_variant | 12/12 | 1 | NM_001082486.2 | ENSP00000478084 | P1 | |
CARMIL2 | ENST00000334583.11 | downstream_gene_variant | 1 | NM_001013838.3 | ENSP00000334958 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152182Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251354Hom.: 0 AF XY: 0.0000294 AC XY: 4AN XY: 135858
GnomAD4 exome AF: 0.0000499 AC: 73AN: 1461830Hom.: 0 Cov.: 35 AF XY: 0.0000454 AC XY: 33AN XY: 727214
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152300Hom.: 0 Cov.: 33 AF XY: 0.0000537 AC XY: 4AN XY: 74476
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Apr 16, 2021 | DNA sequence analysis of the ACD gene demonstrated a sequence change, c.1370C>T, in exon 12 that results in an amino acid change, p.Pro457Leu. This sequence change has been described in gnomAD with a frequency of 0.012% in the African sub-population (dbSNP rs150387011). The p.Pro457Leu change affects a poorly conserved amino acid residue located in a domain of the ACD protein that is not known to be functional. The p.Pro457Leu substitution appears to be benign using several in-silico pathogenicity prediction tools (SIFT, PolyPhen2, Align GVGD, REVEL). This sequence change does not appear to have been previously described in patients with ACD-related disorders. Due to the lack of sufficient evidences, the clinical significance of the p.Pro457Leu change remains unknown at this time. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2021 | The p.P543L variant (also known as c.1628C>T), located in coding exon 12 of the ACD gene, results from a C to T substitution at nucleotide position 1628. The proline at codon 543 is replaced by leucine, an amino acid with similar properties. This amino acid position is conserved. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Dyskeratosis congenita, autosomal dominant 6 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2024 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 543 of the ACD protein (p.Pro543Leu). This variant is present in population databases (rs150387011, gnomAD 0.008%). This variant has not been reported in the literature in individuals affected with ACD-related conditions. ClinVar contains an entry for this variant (Variation ID: 1337912). An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at